Other Bacterial Zinc Peptidases as Potential Drug Targets

Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications

Volumn , Issue , 2009, Pages 731-747

  Watanabe, Kunihiko ^a  

^a KYOTO PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Lactamantibiotics clinical drugs having lethal action on wide spectrum of bacteria; Immunoglobulin A1 proteinase from Streptococcus pneumoniae; Other bacterial zinc peptidases as potential drug targets

Indexed keywords

EID: 79958217656     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470508169.ch31     Document Type: Chapter

References (89)

1. Frére, J. M. b-Lactamases and bacterial resistance to antibiotics. Mol. Microbiol. 1995, 16, 385-395.
2. Livermore, D. M.; Woodford, N. The b-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 2006, 14, 413-420.
3. Frére, J. M.; Galleni, M.; Bush, K.; Dideberg, O. Is it necessary to change the classification of b-lactamases? J. Antimicrob. Chemother. 2005, 55, 1051-1053.
4. Hall, B. G.; Salipante, S. J.; Barlow, M. The metallo-b-lactamases fall into two distinct phylogenetic groups. J. Mol. Evol. 2003, 57, 249-254.
5. Walsh, T. R.; Toleman, M. A.; Poirel, L.; Nordmann, P. Metallo-b-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 2005, 18, 306-325.
6. Garau, G.; Di Guilmi, A. M.; Hall, B. G. Structure-based phylogeny of the metallo-blactamases. Antimicrob. Agents Chemother. 2005, 49, 2778-2784.
7. Carfi, A.; Pares, S.; Duée, E.; Galleni, M.; Duez, C.; Frére, J. M.; Dideberg, O. The 3-D structure of a zinc metallo-b-lactamase from Bacillus cereus reveals a new type of protein fold. EMBO J. 1995, 14, 4914-4921.
8. Fabiane, S. M.; Sohi, M. K.;Wan, T.; Payne, D. J.; Bateson, J. H.; Mitchell, T.; Sutton, B. J. Crystal structure of the zinc-dependent b-lactamase from Bacillus cereus at 1.9 Å resolution: binuclear active site with features of a mononuclear enzyme. Biochemistry 1998, 37, 12404-12411.
9. Concha, N. O.; Rasmussen, B. A.; Bush, K.; Herzberg, O. Crystal structure of the widespectrum binuclear zinc b-lactamase from Bacteroides fragilis. Structure 1996, 4, 823-836.
10. Ullah, J. H.; Walsh, T. R.; Taylor, I. A.; Emery, D. C.; Verma, C. S.; Gamblin, S. J.; Spencer, J. The crystal structure of the L1 metallo-b-lactamase from Stenotrophomonas maltophilia at 1.7 Å resolution. J. Mol. Biol. 1998, 284, 125-136.
11. García-Sáez, I.; Mercuri, P. S.; Papamicael, C.; Kahn, R.; Frére, J. M.; Galleni, M.; Rossolini, G. M.; Dideberg, O. Three-dimensional structure of FEZ-1, a monomeric subclass B3 metallo-b-lactamase from Fluoribacter gormanii, in native form and in complex with D-captopril. J. Mol. Biol. 2003, 325, 651-660.
12. Garau, G.; Bebrone, C.; Anne, C.; Galleni, M.; Frére, J. M.; Dideberg, O. A metallo-blactamase enzyme in action: crystal structures of the monozinc carbapenemase CphA and its complex with biapenem. J. Mol. Biol. 2005, 345, 785-795.
13. Hernandez-Valladares, M.; Felici, A.; Weber, G.; Adolph, H. W.; Zeppezauer, M.; Rossolini, G. M.; Amicosante, G.; Frére, J. M.; Galleni, M. Zn(II) dependence of the Aeromonas hydrophila AE036 metallo-b-lactamase activity and stability. Biochemistry 1997, 36, 11534-11541.
14. Walter,M.W.; Felici, A.; Galleni, M.; Soto, R. P.; Adlington, R. M.; Baldwin, J. E.; Frére, J.-M.; Gololobov, M.; Schofield, C. J. Trifluoromethyl alcohol and ketone inhibitors of metallo-b-lactamases. Bioorg. Med. Chem. Lett. 1996, 6, 2455-2458.
15. Walter, M.W.; Hernandez-Valladares, M.; Adlington, R. M.; Amicosante, G.; Baldwin, J. E.; Frére, J. M.; Galleni, M.; Rossolini, G. M.; Schofield, C. J. Hydroxamate inhibitors of Aeromonas hydrophila AE036 metallo-b-lactamase. Bioorg. Chem. 1999, 27, 35-40.
16. Arawaka,Y.; Shibata, N.; Shibayama, K.; Kurokawa, H.;Yagi, T.; Fujiwara, H.; Goto, M. Convenient test for screening metallo-b-lactamase-producing Gram-negative bacteria by using thiol compounds. J. Clin. Microbiol. 2000, 38, 40-43.
17. Goto, M.; Takahashi, T.; Yamashita, F.; Koreeda, A.; Mori, H.; Ohta, M.; Arakawa, Y. Inhibition of the metallo-b-lactamase produced from Serratia marcescens by thiol compounds. Biol. Pharm. Bull. 1997, 20, 1136-1140.
18. Bounaga, S.; Laws, A. P.; Galleni, M.; Page, M. I. The mechanism of catalysis and the inhibition of the Bacillus cereus zinc-dependent b-lactamase. Biochem. J. 1998, 331, 703-711.
19. Bounaga, S.; Galleni, M.; Laws, A. P.; Page, M. I. Cysteinyl peptide inhibitors of Bacillus cereus zinc b-lactamase. Bioorg. Med. Chem. 2001, 9, 503-510.
20. Greenlee, M. L.; Laub, J. B.; Balkovec, J. M.; Hammond, M. L.; Hammond, G. G.; Pompliano, D. L.; Epstein-Toney, J. H. Synthesis and SAR of thioester and thiol inhibitors of IMP-1 metallo-b-lactamase. Bioorg. Med. Chem. Lett. 1999, 9, 2549-2554.
21. Payne, D. J.; Bateson, J. H.; Gasson, B. C.; Proctor, D.; Khushi, T.; Farmer, T. H.; Toldon, D. A.; Bell, D.; Skett, P.W.; Marshall, A. C.; Reid, R.; Ghosez, L.; Combret, Y.; Marchand-Brynaert, J. Inhibition of metallo-b-lactamases by a series of mercaptoacetic acid thiol ester derivatives. Antimicrob. Agents Chemother. 1997, 41, 135-140.
22. Payne, D. J.; Bateson, J. H.; Gasson, B. C.; Khushi, T.; Proctor, D.; Pearson, S. C.; Reid, R. Inhibition of metallo-b-lactamases by a series of thiol ester derivatives of mercaptophenylacetic acid. FEMS Microbiol. Lett. 1997, 157, 171-175.
23. Hammond, G. G.; Huber, J. L.; Greenlee, M. L.; Laub, J. B.; Young, K.; Silver, L. L.; Balkovec, J. M.; Pryor, K. D.; Wu, J. K.; Leiting, B.; Pompliano, D. L.; Toney, J. H. Inhibition of IMP-1 metallo-b-lactamase and sensitisation of IMP-1-producing bacteria by thioester derivatives. FEMS Microbiol. Lett. 1999, 179, 289-296.
24. Mollard, C.; Moali, C.; Papamicael, C.; Damblon, C.; Vessilier, S.; Amicosante, G.; Schofield, C. J.; Galleni, M.; Frére, J. M.; Roberts, G. C. K. Thiomandelic acid, a broadspectrum inhibitor of zinc b-lactamases: kinetic and spectroscopic studies. Biol. Chem. 2001, 276, 45015-45023.
25. Toney, J. H.; Cleary, K. A.; Hammond, G. G.; Yuan, X.; May, W. J.; Hutchins, S. M.; Ashton,W. T.; Vanderwall, D. E. Structure-activity relationships of biphenyl tetrazoles as metallo-b-lactamase inhibitors. Bioorg. Med. Chem. Lett. 1999, 9, 2741-2746.
26. Toney, J. H.; Hammond, G. G.; Fitzgerald, P. M.; Sharma, N.; Balkovec, J. M.; Rouen, G. P.; Olson, S. H.; Hammond, M. L.; Greenlee, M. L.; Gao, Y. D. Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-b-lactamase. J. Biol. Chem. 2001, 276, 31913-31918.
27. Payne, D. J.; Hueso-Rodríguez, J. A.; Boyd, H.; Concha, N. O.; Janson, C. A.; Gilpin, M.; Bateson, J. H.; Cheever, C.; Niconovich, N. L.; Pearson, S.; Rittenhouse, S.; Tew, D.;Díez, E.; Pérez, P.; De La Fuente, J.; Rees, M.; Rivera-Sagredo, A. Identification of a series of tricyclic natural products as potent broad-spectrum inhibitors of metallo-b-lactamases. Antimicrob. Agents Chemother. 2002, 46, 1880-1886.
28. Siemann, S.; Evanoff, D. P.; Marrone, L.; Clarke, A. J.; Viswantha, T.; Dimitrenko, G. I. N-arylsulfonyl hydrazones as inhibitors of IMP-1 metallo-b-lactamase. Antimicrob. Agents Chemother. 2002, 46, 2450-2457.
29. Heinz, U.; Bauer, R.; Wommer, S.; Meyer-Klaucke, W.; Papamichaels, C.; Bateson, J.; Adolph, H. W. Coordination geometries of metal ions in D- or L-captopril-inhibited metallo-b-lactamases. J. Biol. Chem. 2003, 278, 20659-20666.
30. Horsfall, L. E.; Garau, G.; Liénard, B. M.; Dideberg, O.; Schofield, C. J.; Frére, J. M.; Galleni, M. Competitive inhibitors of the CphA metallo-b-lactamase from Aeromonas hydrophila. Antimicrob. Agents Chemother. 2007, 51, 2136-2142.
31. Rossier, O.; Dao, J.; Cianciotto, N. P. The type II secretion system of Legionella pneumophila elaborates two aminopeptidases, as well as a metalloprotease that contributes to differential infection among protozoan hosts. Appl. Environ. Microbiol. 2008, 74, 753-761.
32. Hales, L. M.; Shuman, H. A. Legionella pneumophila contains a type II general secretion pathway required for growth in amoebae as well as for secretion of the Msp protease. Infect. Immun. 1999, 67, 3662-3666.
33. Liles, M. R.; Edelstein, P. H.; Cianciotto, N. P. The prepilin peptidase is required for protein secretion by and the virulence of the intracellular pathogen Legionella pneumophila. Mol. Microbiol. 1999, 31, 959-970.
34. Moffat, J. F.; Black, W. J.; Tompkins, L. S. Further molecular characterization of the cloned Legionella pneumophila zinc metalloprotease. Infect. Immun. 1994, 62, 751-753.
35. Quinn, F. D.; Tompkins, L. S. Analysis of a cloned sequence of Legionella pneumophila encoding a 38 kD metalloprotease possessing haemolytic and cytotoxic activities. Mol. Microbiol. 1989, 3, 797-805.
36. Szeto, L.; Shuman, H. A. The Legionella pneumophila major secretory protein, a protease, is not required for intracellular growth or cell killing. Infect. Immun. 1990, 58, 2585-2592.
37. Keen, M. G.; Hoffman, P. S. Characterization of a Legionella pneumophila extracellular protease exhibiting haemolytic and cytotoxic activities. Infect. Immun. 1989, 57, 732-738.
38. Black,W. G.; Quinn, F. D.; Tompkins, L. S. Legionella pneumophila zinc metalloprotease is structurally and functionally homologous to Pseudomonas aeruginosa elastase. J. Bacteriol. 1990, 172, 2608-2613.
39. Dreyfus, L. A.; Iglewski, B. H. Purification and characterization of an extracellular protease of Legionella pneumophila. Infect. Immun. 1986, 51, 736-743.
40. Häse, C. C.; Finkelstein, R. A. Cloning and nucleotide sequence of the Vibrio cholerae hemagglutinin/protease (HA/protease) gene and construction of an HA/protease-negative strain. J. Bacteriol. 1991, 173, 3311-3317.
41. Finkelstein, R. A.; Boesman-Finkelstein, M.; Holt, P. Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited. Proc. Natl. Acad. Sci. USA 1983, 80, 1092-1095.
42. Mel, S. F.; Fullner, K. J.;Wimer-Mackin, S.; Lencer, W. I.; Mekalanos, J. J. Association of protease activity in Vibrio cholerae vaccine strains with decreases in transcellular epithelial resistance of polarized T84 intestinal epithelial cells. Infect. Immun. 2000, 68, 6487-6492.
43. Wu, Z.; Milton, D.; Nybom, P.; Sjö, A.; Magnusson, K. E. Vibrio cholerae hemagglutinin/protease (HA/protease) causes morphological changes in cultured epithelial cells and perturbs their paracellular barrier function. Microb. Pathog. 1996, 21, 111-123.
44. Wu, Z.; Nybom, P.; Magnusson, K. E. Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell. Microbiol. 2000, 2, 11-17.
45. Silva, A. J.; Pham, K.; Benitez, J. A. Haemagglutinin/protease expression and mucin gel penetration in El Tor biotype Vibrio cholerae. Microbiology 2003, 149, 1883-1891.
46. Xu, Q.; Dziejman, M.; Mekalanos, J. J. Determination of the transcriptome of Vibrio cholerae during intraintestinal growth and midexponential phase in vitro. Proc. Natl Acad. Sci. USA 2003, 100, 1286-1291.
47. Ghosh, A.; Saha, D. R.; Hoque, K. M.; Asakuna, M.; Yamasaki, S.; Koley, H.; Das, S. S.; Chakrabarti, M. K.; Pal, A. Enterotoxigenicity of mature 45-kilodalton and processed 35- kilodalton forms of hemagglutinin protease purified from a cholera toxin gene-negative Vibrio cholerae non-O1, non-O139 strain. Infect. Immun. 2006, 74, 2937-2946.
48. Benítez, J. A.; García, L.; Silva, A.; García, H.; Fando, R.; Cedré, B.; Pérez, A.; Campos, J.; Rodríguez, B. L.; Pérez, J. L.;Valmaseda, T.; Pérez, O.; Pérez, A.;Ramírez, M.; Ledón, T.; Jidy M. D.; Lastre, M.; Bravo, L.; Sierra, G. Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate. Infect. Immun. 1999, 67, 539-545.
49. Crowther, R. S.; Roomi, N. W.; Fahim, R. E.; Forstner, J. F. Vibrio cholerae metalloproteinase degrades intestinal mucin and facilitates enterotoxin-induced secretion from rat intestine. Biochim. Biophys. Acta 1987, 924, 393-402.
50. Lutfullah, G.; Amin, F.; Khan, Z.; Azhar, N.; Azim, M. K.; Noor, S.; Shoukat, K. Homology modeling of hemagglutinin/protease [HA/P (vibriolysin)] from Vibrio Cholerae: sequence comparison, residue interactions and molecular mechanism. Protein J. 2008, 27, 105-114.
51. Wünsch, E.; Heidrich, H. G. Zur quantitiativen Bestimmung der Kollagenase. Hoppe-Seyler's Z. Physiol. Chem. 1963, 333, 149-151.
52. Watanabe, K. Collagenolytic proteases from bacteria. Appl. Microbiol. Biotechnol. 2004, 63, 520-526.
53. Miyake, R.; Shigeri, Y.; Tatsu, Y.; Yumoto, N.; Umekawa, M.; Tsujimoto, Y.; Matsui, H.; Watanabe, K. Two thimet oligopeptidase-like Pz peptidases produced by a collagendegrading thermophile, Geobacillus collagenovorans MO-1. J. Bacteriol. 2005, 187, 4140-4148.
54. Ibrahim-Granet, O.; D'Enfert, C. The Aspergillus fumigatus mepB gene encodes an 82 kDa intracellular metalloproteinase structurally related to mammalian thimet oligopeptidases. Microbiology 1997, 143, 2247-2253.
55. Barrett, A. J.; Chen, J. M. TOP. In Handbook of Proteolytic Enzymes, 2nd ed; Barrett, A. J.; Rawlings, N. D.; Woessner J. F., Eds.; Elsevier: 2004; pp. 352-356.
56. Ray, K.;Hines, C. S.; Coll-Rodriguez, J.; Rodgers,D.W. Crystal structure of human thimet oligopeptidase provides insight into substrate recognition, regulation, and localization. J. Biol. Chem. 2004, 279, 20480-20489.
57. Kawasaki, A.; Nakano, H.; Tsujimoto, Y.; Matsui, H.; Shimizu, T.; Nakatsu, T.; Kato, H.; Watanabe, K. Crystallization and preliminary X-ray crystallographic studies of Pz peptidase A from Geobacillus collagenovorans MO-1. Acta. Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2007, 63, 142-144.
58. Jiracek, J.; Yiotakis, A.; Vincent, B.; Checler, F.; Dive, V. Development of the first potent and selective inhibitor of the zinc endopeptidase neurolysin using a systematic approach based on combinatorial chemistry of phosphinic peptides. J. Biol. Chem. 1996, 271, 19606-19611.
59. Sugihara, Y.; Kawasaki, A.; Tsujimoto, Y.; Matsui, H.; Watanabe, K. Potencies of phosphine peptide inhibitors of mammalian thimet oligopeptidase and neurolysin on two bacterial Pz peptidases. Biosci. Biotechnol. Biochem. 2007, 71, 594-597.
60. Plaut, A. G.; Wright, A. Immunoglobulin A-metallo-type specific prolyl endopeptidases. Methods Enzymol. 1995, 248, 634-642.
61. Plaut, A. G. IgA1-specificmetalloendopeptidase. In Handbook ofProteolyticEnzymes;2edn; Barrett, A. J.; Rawlings, N. D.;Woessner, J. F., Eds.; Elsevier: London, 2004; pp 772-776.
62. Senior, B. W.; Dunlop, J. I.; Batten, M. R.; Kilian, M.; Woof, J. M. Cleavage of a recombinant human immunoglobulin A2 (IgA2)-IgA1 hybrid antibody by certain bacterial IgA1 proteases. Infect. Immun. 2000, 68, 463-469.
63. Qiu, J.; Brackee, G. P.; Plaut, A. G. Analysis of the specificity of bacterial immunoglobulin A (IgA) proteases by a comparative study of ape serum IgAs as substrates. Infect. Immun. 1996, 64, 933-937.
64. Schneewind, O.; Mihaylova-Petkov, D.; Model, P. Cell wall sorting signals in surface proteins of gram-positive bacteria. EMBO J. 1993, 12, 4803-4811.
65. Romanello, V.; Marcacci, M.; Dal Molin, F.; Moschioni, M.; Censini, S.; Covacci, A.; Baritussio, A. G.; Montecucco, C.; Tonello, F. Cloning, expression, purification, and characterization of Streptococcus pneumoniae IgA1 protease. Protein Expr. Purif. 2006, 45, 142-149.
66. Walker, S. G.; Carnu, O. I.; Tüter, G.; Ryan, M. E. The immunoglobulinA1proteinase from Streptococcus pneumoniae is inhibited by tetracycline compounds. FEMS Immunol. Med. Microbiol. 2006, 48, 218-222.
67. Nelson, M. L. Chemical and biological dynamics of tetracyclines. Adv. Dent. Res. 1998, 12, 5-11.
68. Grenier, D.; Plamondon, P.; Sorsa, T.; Lee, H. M.; McNamara, T.; Ramamurthy, N. S.; Golub, L. M.; Teronen, O.; Mayrand, D. Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives. J. Periodontol. 2002, 73, 79-85.
69. Blue, C. E.; Paterson, G. K.; Kerr, A. R.; Bergé, M.; Claverys, J. P.; Mitchell, T. J. ZmpB, a novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis factor a production in the respiratory tract. Infect. Immun. 2003, 71, 4925-4935.
70. Oggioni, M. R.; Memmi, G.; Maggi, T.; Chiavolini, D.; Iannelli, F.; Pozzi, G. Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia. Mol. Microbiol. 2003, 49, 795-805.
71. Lathem,W.W.; Grys, T. E.;Witowski, S. E.; Torres, A. G.; Kaper, J. B.; Tarr, P. I.;Welch, R. A. StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor. Mol. Microbiol. 2002, 45, 277-288.
72. Lathem,W.W.; Bergsbaken, T.;Welch, R. A. Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7. J. Exp. Med. 2004, 199, 1077-1087.
73. Huntington, J. A.; Read, R. J.; Carrell, R.W. Structure of a serpin-protease complex shows inhibition by deformation. Nature 2000, 407, 923-926.
74. Grys, T. E.; Siegel, M. B.; Lathem, W. W.; Welch, R. A. The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cells. Infect. Immun. 2005, 73, 1295-1303.
75. Uttley, A. H.; Collins, C. H.; Naidoo, J.; George, R. C. Vancomycin-resistant enterococci. Lancet 1988, 1, 57-58.
76. Leclercq, R.; Derlot, E.; Duval, J.; Courvalin, P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 1988, 319, 157-161.
77. Arthur, M.; Depardieu, F.; Cabanié, L.; Reynolds, P.; Courvalin, P. Requirement of the VanYand VanX D,D-peptidases for glycopeptide resistance in enterococci. Mol. Microbiol. 1998, 30, 819-830.
78. Arthur, M.; Molinas, C.; Courvalin, P. The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 1992, 174, 2582-2591.
79. Walsh, C. T.; Fisher, S. L.; Park, I. S.; Prahalad, M.; Wu, Z. Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story. Chem. Biol. 1996, 3, 21-28.
80. Lessard, I. A.; Walsh, C. T. VanX, a bacterial D-alanyl-D-alanine dipeptidase: resistance, immunity, or survival function? Proc. Natl. Acad. Sci. USA 1999, 96, 11028-11032.
81. Bugg, T. D.; Wright, G. D.; Dutka-Malen, S.; Arthur, M.; Courvalin, P.; Walsh, C. T. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteinsVanH and VanA. Biochemistry 1991, 30, 10408-10415.
82. Breece, R. M.; Costello, A.; Bennett, B.; Sigdel, T. K.; Matthews, M. L.; Tierney, D. L.; Crowder,M.W. A five-coordinate metal center in Co(II)-substituted VanX. J. Biol. Chem. 2005, 280, 11074-11081.
83. Bussiere, D. E.; Pratt, S. D.; Katz, L.; Severin, J. M.; Holzman, T.; Park, C. H. The structure of VanX reveals a novel amino-dipeptidase involved in mediating transposon-based vancomycin resistance. Mol. Cell. 1998, 2, 75-84.
84. Gao, Y. Glycopeptide antibiotics and development of inhibitors to overcome vancomycin resistance. Nat. Prod. Rep. 2002, 19, 100-107.
85. Lessard, I. A.;Walsh, C. T. Mutational analysis of active-site residues of the enterococcal D-ala-D-Ala dipeptidaseVanX and comparison with Escherichia coliD-ala-D-Ala ligase and D-ala-D-Ala carboxypeptidase VanY. Chem. Biol. 1999, 6, 177-187.
86. Wu, Z.;Walsh, C.T. Dithiol compounds: potent, time-dependent inhibitors ofVanX, a zincdependent D, D-dipeptidase required for vancomycin resistance in Enterococcus faecium. J. Am. Chem. Soc. 1996, 118, 1785-1786.
87. Wu, Z.;Walsh, C. T. Phosphinate analogs of D-, D-dipeptides: slow-binding inhibition and proteolysis protection of VanX, a D-, D-dipeptidase required for vancomycin resistance in Enterococcus faecium. Proc. Natl. Acad. Sci. USA 1995, 92, 11603-11607.
88. Ellsworth, B. A.; Tom, N. J.; Bartlett, P. A. Synthesis and evaluation of inhibitors of bacterial D-alanine:D-alanine ligases. Chem. Biol. 1996, 3, 37-44.
89. Aráoz, R.; Anhalt, E.; René, L.; Badet-Denisot, M. A.; Courvalin, P.; Badet, B. Mechanismbased inactivation of VanX, a D-alanyl-D-alanine dipeptidase necessary for vancomycin resistance. Biochemistry 2000, 39, 15971-15979.